No Data
No Data
No Data
No Data
No Data
Bod Science Announces Delay in Appendix 4D Lodgement
Bod Science (ASX:BOD) said its appendix 4D, or half-year report, for the six months ended Dec. 31, 2023, will be delayed anew following a rejection by the the Australian Securities and Investments Com
MT NewswiresMar 26 05:43
BOD Science Signs Supply Agreement in Medicinal Cannabis With Green Farmers
BOD Science (ASX:BOD) signed a supply agreement with licensed cultivator, importer, and genetic holder of medicinal cannabis, Green Farmers, according to a Wednesday release. BOD Science will supply a
MT NewswiresDec 13, 2023 18:32
Bod Science Receives AU$1.6 Million R&D Tax Refund; Shares Rise 8%
Bod Science (ASX:BOD) received a more than AU$1.6 million of research and development tax rebate for fiscal 2023. The rebate fully covers the outstanding AU$1.2 million loan payable to Radium Capital,
MT NewswiresNov 22, 2023 11:02
Bod Expects to Receive Funds From Antah Soon
Bod Science (ASX:BOD) provided an update on its capital raising program, saying it did not secure the AU$440,000 on Nov. 20, because of a delay in the receipt of funds from investor Antah Healthcare G
MT NewswiresNov 21, 2023 21:13
Bod Science Delays Settlement of Tranche 1 of AU$2.1 Million Placement
The settlement of the first tranche of Bod Science's (ASX:BOD) placement to raise AU$2.1 million has been delayed to Nov. 20. The shares were originally expected to be issued on Monday, Nov. 14, the m
MT NewswiresNov 16, 2023 18:21
Bod Science Raises AU$2.1 Million Via Share Placement; Shares Fall 43%
Bod Science (ASX:BOD) raised AU$2.1 million via a two-tranche placement priced at AU$0.03 per share. Proceeds will be used to build the cannabis drug developer's inventory, manufacture products, for w
MT NewswiresNov 8, 2023 11:12
No Data
No Data